Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany

Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany

Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s12325-016-0376-8 Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Plöthner, Marika, Ribbentrop, Dana, Jan-Phillipp Hartman, Frank, Martin
Format: Bild
Sprache:eng
Schlagworte:
Medicine
Pharmacology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Plöthner, Marika
Ribbentrop, Dana
Jan-Phillipp Hartman
Frank, Martin
description Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s12325-016-0376-8 Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com. The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content. Other enhanced features include, but are not limited to: • Slide decks • Videos and animations • Audio abstracts • Audio slides
doi_str_mv 10.6084/m9.figshare.6445688
format Image
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_6445688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_6445688</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_64456883</originalsourceid><addsrcrecordid>eNqdT8tOwzAQzIUDAr6Ai3-gIVVDlHKLqlIuSIjmbi3OuFmptiPbDQpfxufhoCLBldNqZ-exk2W3yyKvirq8M-tc8yH05JFXZXlf1fVl9rlxIS62WkNFHmERgnBavCSWIeUOsM6wEmS73xhiwlok5e7EHdINPjhLR_5IS9vD08AID6IR-ylEGJoFrxgZ77N97CGaYfBuTPTmO1nsT28hklUIQjv_1_EZHSu2EGzFDukLO11nF5qOATfneZWtHrft5mnRUSTFEXLwbMhPclnIub80a_nTX577r_6n-gJaaXLt</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany</title><source>DataCite</source><creator>Plöthner, Marika ; Ribbentrop, Dana ; Jan-Phillipp Hartman ; Frank, Martin</creator><creatorcontrib>Plöthner, Marika ; Ribbentrop, Dana ; Jan-Phillipp Hartman ; Frank, Martin</creatorcontrib><description>Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s12325-016-0376-8 Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com. The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content. Other enhanced features include, but are not limited to: • Slide decks • Videos and animations • Audio abstracts • Audio slides</description><identifier>DOI: 10.6084/m9.figshare.6445688</identifier><language>eng</language><publisher>Adis Journals</publisher><subject>Medicine ; Pharmacology</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>782,1896</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.6445688$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Plöthner, Marika</creatorcontrib><creatorcontrib>Ribbentrop, Dana</creatorcontrib><creatorcontrib>Jan-Phillipp Hartman</creatorcontrib><creatorcontrib>Frank, Martin</creatorcontrib><title>Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany</title><description>Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s12325-016-0376-8 Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com. The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content. Other enhanced features include, but are not limited to: • Slide decks • Videos and animations • Audio abstracts • Audio slides</description><subject>Medicine</subject><subject>Pharmacology</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2018</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqdT8tOwzAQzIUDAr6Ai3-gIVVDlHKLqlIuSIjmbi3OuFmptiPbDQpfxufhoCLBldNqZ-exk2W3yyKvirq8M-tc8yH05JFXZXlf1fVl9rlxIS62WkNFHmERgnBavCSWIeUOsM6wEmS73xhiwlok5e7EHdINPjhLR_5IS9vD08AID6IR-ylEGJoFrxgZ77N97CGaYfBuTPTmO1nsT28hklUIQjv_1_EZHSu2EGzFDukLO11nF5qOATfneZWtHrft5mnRUSTFEXLwbMhPclnIub80a_nTX577r_6n-gJaaXLt</recordid><startdate>20180605</startdate><enddate>20180605</enddate><creator>Plöthner, Marika</creator><creator>Ribbentrop, Dana</creator><creator>Jan-Phillipp Hartman</creator><creator>Frank, Martin</creator><general>Adis Journals</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20180605</creationdate><title>Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany</title><author>Plöthner, Marika ; Ribbentrop, Dana ; Jan-Phillipp Hartman ; Frank, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_64456883</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Medicine</topic><topic>Pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Plöthner, Marika</creatorcontrib><creatorcontrib>Ribbentrop, Dana</creatorcontrib><creatorcontrib>Jan-Phillipp Hartman</creatorcontrib><creatorcontrib>Frank, Martin</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Plöthner, Marika</au><au>Ribbentrop, Dana</au><au>Jan-Phillipp Hartman</au><au>Frank, Martin</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany</title><date>2018-06-05</date><risdate>2018</risdate><abstract>Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s12325-016-0376-8 Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com. The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content. Other enhanced features include, but are not limited to: • Slide decks • Videos and animations • Audio abstracts • Audio slides</abstract><pub>Adis Journals</pub><doi>10.6084/m9.figshare.6445688</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.6445688
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_6445688
source DataCite
subjects Medicine
Pharmacology
title Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T22%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Pl%C3%B6thner,%20Marika&rft.date=2018-06-05&rft_id=info:doi/10.6084/m9.figshare.6445688&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_6445688%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true